Amgen to Acquire Five Prime Therapeutics

Amgen Ranks as One of Barron's 100 Most Sustainable Companies

The list reflects the growing attention being paid to how companies perform on a variety of non-financial measures.

Candid Conversations: Women Empowered to be Exceptional (WE2)

A short video series featuring Amgen leaders addressing topics of Diversity, Inclusion and Belonging — issues at the intersection of the workplace and society.

Tezepelumab Is the First Biologic to Significantly Reduce Exacerbations in Broad Population of Patients With Severe, Uncontrolled Asthma

Visit Our KRAS G12C Information Center

Learn more about our pioneering research in taking on one of cancer research’s toughest challenges, and hear first-hand from patients and Amgen scientists.